Cytokinetics Grants Stock Options and RSUs Under Nasdaq Inducement Rule
Cytokinetics said it granted options covering 60,465 shares and 40,084 restricted stock units on October 15, 2026, under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Cytokinetics grants inducement stock options and RSUs under Nasdaq rule
Cytokinetics said inducement grants were made on Sept. 15, 2026: stock options for 52,834 shares and RSUs for 35,025 shares to be settled in common stock.